Optimizing renal replacement therapy in older adults: A framework for making individualized decisions

Kidney International

Volumn 82, Issue 3, 2012, Pages 261-269

  Tamura, Manjula Kurella ^a,b   Tan, Jane C ^a   O'Hare, Ann M ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

dialysis; elderly; end stage renal disease; transplantation

Indexed keywords

AGE DISTRIBUTION; BACTEREMIA; CATHETER INFECTION; ELDERLY CARE; GRAFT FAILURE; HEMODIALYSIS; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PATIENT PREFERENCE; PATIENT SATISFACTION; PERITONEAL DIALYSIS; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SURVIVAL RATE; VASCULAR ACCESS;

EID: 84863794930     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.384     Document Type: Review

References (48)

1. O'Hare AM, Rodriguez RA, Hailpern SM et al. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA 2010; 304: 180-186.
2. Kurella M, Covinsky KE, Collins AJ et al. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007; 146: 177-183. (Pubitemid 351650630)
3. Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-724. (Pubitemid 41159291)
4. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750-2756. (Pubitemid 32525372)
5. Bogardus Jr ST, Holmboe E, Jekel JF. Perils, pitfalls, and possibilities in talking about medical risk. JAMA 1999; 281: 1037-1041. (Pubitemid 29143898)
6. Moss AH, Ganjoo J, Sharma S et al. Utility of the 'surprise' question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008; 3: 1379-1384.
7. Miskulin DC, Martin AA, Brown R et al. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant 2004; 19: 413-420. (Pubitemid 38195992)
8. Cohen LM, Ruthazer R, Moss AH et al. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010; 5: 72-79.
9. Couchoud C, Labeeuw M, Moranne O et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24: 1553-1561.
10. Geddes CC, van Dijk PC, McArthur S et al. The ERA-EDTA cohort study - comparison of methods to predict survival on renal replacement therapy. Nephrol Dial Transplant 2006; 21: 945-956.
11. Mehrotra R, Chiu YW, Kalantar-Zadeh K et al. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171: 110-118.
12. Weinhandl ED, Foley RN, Gilbertson DT et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21: 499-506.
13. Jaar BG, Plantinga LC, Crews DC et al. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol 2009; 10: 3.
14. Lim W, Dogra G, McDonald SP et al. Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int 2011 (e-pub ahead of print).
15. Wu AW, Fink NE, Marsh-Manzi JV et al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol 2004; 15: 743-753. (Pubitemid 38294805)
16. Shih YC, Guo A, Just PM et al. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 2005; 68: 319-329. (Pubitemid 43181391)
17. Collins AJ, Foley RN, Herzog C et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 2010; 55: S1-420, A426-427.
18. Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005; 143: 174-183.
19. Perl J, Wald R, McFarlane P et al. Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011; 22: 1113-1121.
20. Bass EB, Wills S, Fink NE et al. How strong are patients' preferences in choices between dialysis modalities and doses? Am J Kidney Dis 2004; 44: 695-705. (Pubitemid 39237614)
21. Oliver MJ, Verrelli M, Zacharias JM et al. Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol Dial Transplant 2011 (e-pub ahead of print).
22. Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(Suppl 1): S248-S273.
23. Peterson WJ, Barker J, Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol 2008; 3: 437-441.
24. Levine MI. A challenge for nephrologists - increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States. Semin Dial 2008; 21: 280-284.
25. Foley RN, Chen SC, Collins AJ. Hemodialysis access at initiation in the United States, 2005 to 2007: still 'catheter first'. Hemodial Int 2009; 13: 533-542.
26. Xue H, Lacson Jr E, Wang W et al. Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis. Clin J Am Soc Nephrol 2010; 5: 2289-2296.
27. Ravani P, Parfrey P, MacRae J et al. Modeling survival of arteriovenous accesses for hemodialysis: semiparametric versus parametric methods. Clin J Am Soc Nephrol 2010; 5: 1243-1248.
28. Allon M, Lok CE. Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol 2010; 5: 2348-2354.
29. O'Hare AM, Allon M, Kaufman JS. Whether and when to refer patients for predialysis AV fistula creation: complex decision making in the face of uncertainty. Semin Dial 2010; 23: 452-455.
30. O'Hare AM, Bertenthal D, Walter LC et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007; 71: 555-561. (Pubitemid 46398678)
31. Kaufman SR, Shim JK, Russ AJ. Old age, life extension, and the character of medical choice. J Gerontol B Psychol Sci Soc Sci 2006; 61: S175-S184. (Pubitemid 44115207)
32. Richardson II AI, Leake A, Schmieder GC et al. Should fistulas really be first in the elderly patient? J Vasc Access 2009; 10: 199-202.
33. Klevens RM, Edwards JR, Andrus ML et al. Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006. Semin Dial 2008; 21: 24-28.
34. James MT, Manns BJ, Hemmelgarn BR et al. What0s next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible? Semin Dial 2009; 22: 539-544.
35. Power A, Singh SK, Ashby D et al. Long-term Tesio catheter access for hemodialysis can deliver high dialysis adequacy with low complication rates. J Vasc Interv Radiol 2011; 22: 631-637.
36. Shingarev R, Maya ID, Barker-Finkel J et al. Arteriovenous graft placement in predialysis patients: a potential catheter-sparing strategy. Am J Kidney Dis 2011; 58: 243-247.
37. Danovitch G, Savransky E. Challenges in the counseling and management of older kidney transplant candidates. Am J Kidney Dis 2006; 47: S86-S97.
38. Cooper M, Forland CL. The elderly as recipients of living donor kidneys, how old is too old? Curr Opin Organ Transplant 2011; 16: 250-255.
39. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
40. Rao PS, Merion RM, Ashby VB et al. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007; 83: 1069-1074. (Pubitemid 46659119)
41. Jassal SV, Krahn MD, Naglie G et al. Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol 2003; 14: 187-196. (Pubitemid 36026309)
42. Kiberd B, Boudreault J, Bhan V et al. Access to the kidney transplant wait list. Am J Transplant 2006; 6: 2714-2720. (Pubitemid 44571692)
43. Schold J, Srinivas TR, Sehgal AR et al. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol 2009; 4: 1239-1245.
44. Schaeffner ES, Rose C, Gill JS. Access to kidney transplantation among the elderly in the United States: a glass half full, not half empty. Clin J Am Soc Nephrol 2010; 5: 2109-2114.
45. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726-2733. (Pubitemid 41770102)
46. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998; 280: 1148-1152. (Pubitemid 28457804)
47. Xi W, Harwood L, Diamant MJ et al. Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making. Nephrol Dial Transplant 2011; 26: 3302-3308.
48. Fried TR, Van Ness PH, Byers AL et al. Changes in preferences for life-sustaining treatment among older persons with advanced illness. J Gen Intern Med 2007; 22: 495-501. (Pubitemid 46941205)